[Elsevier] Isoalantolactone/hydroxamic acid hybrids as potent dual STAT3/HDAC inhibitors and self-assembled nanoparticles for cancer therapy |
|
This post will be closed automatically in 2026-08-31 04:16
Reward10points
|
10
Anti-TNF汐 treatment for recalcitrant ulcerative necrobiosis lipoidica diabeticorum: A case report and review of the literature
10
Artificial intelligence and corporate ESG: Evidence from Chinese listed enterprises
10
Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus conventional immunomodulatory therapy: A population-based cohort study
10
Artificial intelligence and corporate ESG performance
10
Direct manufacturing of diamond composite coatings onto silicon wafers and heat transfer performance
